← Leaderboards
Lynn M Matrisian
Vanderbilt University
$19,522,211
Attributed
$22,617,652
Total exposure
26
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$30,844,157 · 27
By mechanism
U54$15,311,538 · 16
R01$9,119,522 · 3
T32$4,289,777 · 2
P50$697,887 · 2
U01$586,007 · 1
R41$522,426 · 1
Top collaborators
- Harold L Moses20 shared
- David P Carbone5 shared
- Yu Shyr5 shared
- Debra M. Wujcik5 shared
- Mary M. Zutter5 shared
- Robert J Coffey4 shared
- Robert J Matusik4 shared
- Wei Zheng4 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Magaly Martinez-Ferrer$909,694
- David L Gorden$1,457,565
- Lisa J McCawley$3,365,459
- Barbara Fingleton$2,662,998
- Harold L Moses$33,288,478
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCancer Health DisparityThe Vanderbilt-Ingram Cancer Center At The Vanderbilt UniversityBaseResearch PersonnelMinorityMolecularMemberResourcesFacultyMetalloendopeptidasesAnticancer ResearchRecruitment ActivityProgramsTumorLaboratory MouseFundingCellsTrainingAfrican AmericanNeoplasm MetastasisGrowthImageProteins
Grant awards (128)
Clinical Trials Core$253,928
U54 · FY2015 · CA
Administration - Recruitment$208,315
U54 · FY2015 · CA
Future Full and Pilot Projects$202,356
U54 · FY2015 · CA
Training$201,657
U54 · FY2015 · CA
Cancer Outreach Core$156,056
U54 · FY2015 · CA
Administration Core$106,833
U54 · FY2015 · CA
Histopathology Core$45,598
U54 · FY2015 · CA
Planning and Evaluation Core$26,303
U54 · FY2015 · CA
Biostatistics Core$22,014
U54 · FY2015 · CA
Clinical Trials Core$254,747
U54 · FY2014 · CA
Administration - Recruitment$210,387
U54 · FY2014 · CA
Training$203,927
U54 · FY2014 · CA
Future Full and Pilot Projects$186,144
U54 · FY2014 · CA
Cancer Outreach Core$159,694
U54 · FY2014 · CA
Administration Core$112,790
U54 · FY2014 · CA
Histopathology Core$52,819
U54 · FY2014 · CA
Planning and Evaluation Core$34,344
U54 · FY2014 · CA
Biostatistics Core$29,953
U54 · FY2014 · CA
Analysis of Serum Exosomes in Patients with Colorectal and Breast Cancer$8,321
U54 · FY2014 · CA
A Multi-Center Epidemiologic Study of Breast Cancer in African-American Women$8,321
U54 · FY2014 · CA
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$8,321
U54 · FY2014 · CA
Clinical Trials Core$237,648
U54 · FY2013 · CA
Training$188,551
U54 · FY2013 · CA
Cancer Outreach Core$145,911
U54 · FY2013 · CA
Administration Core$101,528
U54 · FY2013 · CA
A Multi-Center Epidemiologic Study of Breast Cancer in African-American Women$84,247
U54 · FY2013 · CA
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$67,987
U54 · FY2013 · CA
Analysis of Serum Exosomes in Patients with Colorectal and Breast Cancer$57,816
U54 · FY2013 · CA
Histopathology Core$43,158
U54 · FY2013 · CA
Planning and Evaluation Core$25,586
U54 · FY2013 · CA
Biostatistics Core$21,122
U54 · FY2013 · CA
Administration - Recruitment$2,245
U54 · FY2013 · CA
Clinical Trials Core$254,293
U54 · FY2012 · CA
Training$201,660
U54 · FY2012 · CA
Cancer Outreach Core$156,056
U54 · FY2012 · CA
Proteolytic Beacons in the Non-invasive Assessment of Response to Cancer Therapy$124,767
P50 · FY2012 · CA · contact PI
Administration Core$109,486
U54 · FY2012 · CA
A Multi-Center Epidemiologic Study of Breast Cancer in African-American Women$90,218
U54 · FY2012 · CA
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$73,314
U54 · FY2012 · CA
Analysis of Serum Exosomes in Patients with Colorectal and Breast Cancer$62,115
U54 · FY2012 · CA
Histopathology Core$46,450
U54 · FY2012 · CA
Planning and Evaluation Core$27,913
U54 · FY2012 · CA
Biostatistics Core$22,888
U54 · FY2012 · CA
Tumor and Stromal Metalloproteinases in Breast Cancer$360,864
R01 · FY2011 · CA · contact PI
Clinical Trials Core$272,947
U54 · FY2011 · CA
Training$201,660
U54 · FY2011 · CA
Cancer Outreach Core$156,056
U54 · FY2011 · CA
Proteolytic Beacons in the Non-invasive Assessment of Response to Cancer Therapy$137,420
P50 · FY2011 · CA · contact PI
Administration Core$110,405
U54 · FY2011 · CA
A Multi-Center Epidemiologic Study of Breast Cancer in African-American Women$90,338
U54 · FY2011 · CA
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$73,925
U54 · FY2011 · CA
Analysis of Serum Exosomes in Patients with Colorectal and Breast Cancer$62,400
U54 · FY2011 · CA
Tumor and Stromal Metalloproteinases in Breast Cancer$51,985
R01 · FY2011 · CA · contact PI
Histopathology Core$46,747
U54 · FY2011 · CA
Planning and Evaluation Core$28,472
U54 · FY2011 · CA
Biostatistics Core$23,191
U54 · FY2011 · CA
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$1,419,991
U54 · FY2010 · CA · contact PI
Microenvironmental Influences in Cancer$423,619
T32 · FY2010 · CA · contact PI
Tumor and Stromal Metalloproteinases in Breast Cancer$377,084
R01 · FY2010 · CA · contact PI
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment$270,952
U01 · FY2010 · CA
Host Microenvironment and Bone Metastases$234,576
U54 · FY2010 · CA · contact PI
Proteolytic Beacons in the Non-invasive Assessment of Response to Cancer Therapy$167,837
P50 · FY2010 · CA · contact PI
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$45,050
U54 · FY2010 · CA · contact PI
Microenvironmental Influences in Cancer$43,410
T32 · FY2010 · CA · contact PI
Tumor and Stromal Metalloproteinases in Breast Cancer$15,191
R01 · FY2010 · CA · contact PI
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$2,089,850
U54 · FY2009 · CA · contact PI
Microenvironmental Influences in Cancer$376,117
T32 · FY2009 · CA · contact PI
Tumor and Stromal Metalloproteinases in Breast Cancer$362,783
R01 · FY2009 · CA · contact PI
Host Microenvironment and Bone Metastases$350,055
U54 · FY2009 · CA · contact PI
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment$315,055
U01 · FY2009 · CA
Proteolytic Beacons in the Non-invasive Assessment of Response to Cancer Therapy$163,368
P50 · FY2009 · CA · contact PI
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$52,614
U54 · FY2009 · CA · contact PI
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$1,500,153
U54 · FY2008 · CA · contact PI
Tumor and Stromal Metalloproteinases in Breast Cancer$408,553
R01 · FY2008 · CA · contact PI
Microenvironmental Influences in Cancer$278,912
T32 · FY2008 · CA · contact PI
Training$209,256
U54 · FY2008 · CA · contact PI
Proteolytic Beacons in the Non-invasive Assessment of Response to Cancer Therapy$104,495
P50 · FY2008 · CA · contact PI
Symposium on Extracellular and Membrane Proteases in Cell Signaling$15,000
R13 · FY2008 · CA
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$1,492,097
U54 · FY2007 · CA · contact PI
Tumor and Stromal Metalloproteinases in Breast Cancer$453,591
R01 · FY2007 · CA · contact PI
Training$206,249
U54 · FY2007 · CA · contact PI
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$76,750
U54 · FY2007 · CA · contact PI
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression$1,550,000
U54 · FY2006 · CA · contact PI
Matrilsin and Tumor Progression$650,601
R01 · FY2006 · CA · contact PI
Multidisciplinary Basic Research Training in Cancer$526,977
T32 · FY2006 · CA · contact PI
Tumor and Stromal Metalloproteinases in Breast Cancer$418,177
R01 · FY2006 · CA · contact PI
Training$137,180
U54 · FY2006 · CA · contact PI
Administrative Core$104,498
U54 · FY2006 · CA · contact PI
Multidisciplinary Basic Research Training in Cancer$35,704
T32 · FY2006 · CA · contact PI
Matrilsin and Tumor Progression$649,104
R01 · FY2005 · CA
Multidisciplinary Basic Research Training in Cancer$557,574
T32 · FY2005 · CA
Tumor and Stromal Metalloproteinases in Breast Cancer$377,626
R01 · FY2005 · CA
Small Animal MRI with Protease-Sensing Contrast Agents$264,123
R41 · FY2005 · RR
Training$133,712
U54 · FY2005 · CA
Multidisciplinary Basic Research Training in Cancer$35,704
T32 · FY2005 · CA
Multidisciplinary Basic Research Training in Cancer$35,011
T32 · FY2005 · CA
Matrilsin and Tumor Progression$632,447
R01 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$569,914
T32 · FY2004 · CA
THE METALLOPROTEINASE MATRILYSIN IN BREAST CANCER$376,380
R01 · FY2004 · CA
MRI with Protease-Sensing Contrast Agents$258,303
R41 · FY2004 · RR
Developing the coral implant model of bone metastasis$151,000
R21 · FY2004 · CA
Training$130,346
U54 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$52,902
T32 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$35,011
T32 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$35,011
T32 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$35,011
T32 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$12,096
T32 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$12,015
T32 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$9,922
T32 · FY2004 · CA
Multidisciplinary Basic Research Training in Cancer$488,484
T32 · FY2003 · CA
Matrilsin and Tumor Progression$402,341
R01 · FY2003 · CA
THE METALLOPROTEINASE MATRILYSIN IN BREAST CANCER$367,018
R01 · FY2003 · CA
Matrilsin and Tumor Progression$274,335
R01 · FY2003 · CA
Developing the coral implant model of bone metastasis$151,000
R21 · FY2003 · CA
MATRILYSIN AND TUMOR PROGRESSION$603,420
R01 · FY2002 · CA
Multidisciplinary Basic Research Training in Cancer$529,267
T32 · FY2002 · CA
THE METALLOPROTEINASE MATRILYSIN IN BREAST CANCER$358,524
R01 · FY2002 · CA
MATRIX METALLOPROTEINASES IN LUNG CANCER$0
P50 · FY2002 · CA
MATRILYSIN AND TUMOR PROGRESSION$353,902
R01 · FY2001 · CA
THE METALLOPROTEINASE MATRILYSIN IN BREAST CANCER$350,262
R01 · FY2001 · CA
MATRILYSIN AND TUMOR PROGRESSION$187,500
R01 · FY2001 · CA
MATRIX METALLOPROTEINASES IN LUNG CANCER$0
P50 · FY2001 · CA
MATRIX METALLOPROTEINASES IN LUNG CANCER$0
P50 · FY2001 · CA
MATRILYSIN AND TUMOR PROGRESSION$358,945
R01 · FY2000 · CA
THE METALLOPROTEINASE MATRILYSIN IN BREAST CANCER$342,228
R01 · FY2000 · CA
TRASIN AND TUMOR PROMOTION AND PROGRESSION$316,792
R01 · FY2000 · CA
TRAINING PROGRAM IN BREAST CANCER RESEARCH$197,116
T32 · FY2000 · CA
TRASIN AND TUMOR PROMOTION AND PROGRESSION$69,869
R01 · FY2000 · CA